Ozurdex is a biodegradable dexamethasone implant placed into the vitreous cavity in cases that are predisposed to development of macular edema due to retinal vein occlusion, noninfectious uveitis or diabetes.The implant, from AbbVie, gradually releases…
Anterior migration possible with Ozurdex
Ozurdex is a biodegradable dexamethasone implant placed into the vitreous cavity in cases that are predisposed to development of macular edema due to retinal vein occlusion, noninfectious uveitis or diabetes.The implant, from AbbVie, gradually releases…
Healio AI: AI assistant built on trusted medical sources
More than 60% of health care professionals report having trust and organizational support for using AI in their practices, yet nearly 45% of them do not double-check AI-generated answers, results of a Healio survey showed.“We found that data diversity,…
Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
Ocular Rosacea Underappreciated in Dermatology and Beyond
For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and applying treatments they are already using. Medscape Medical News
Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders
GENEVA–(BUSINESS WIRE)–Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders